AU1598399A - Injectable antifungal formulations - Google Patents
Injectable antifungal formulationsInfo
- Publication number
- AU1598399A AU1598399A AU15983/99A AU1598399A AU1598399A AU 1598399 A AU1598399 A AU 1598399A AU 15983/99 A AU15983/99 A AU 15983/99A AU 1598399 A AU1598399 A AU 1598399A AU 1598399 A AU1598399 A AU 1598399A
- Authority
- AU
- Australia
- Prior art keywords
- antifungal formulations
- injectable
- injectable antifungal
- formulations
- antifungal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nanotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98095097A | 1997-12-01 | 1997-12-01 | |
| US08980950 | 1997-12-01 | ||
| PCT/US1998/024938 WO1999027932A1 (en) | 1997-12-01 | 1998-11-30 | Injectable antifungal formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1598399A true AU1598399A (en) | 1999-06-16 |
Family
ID=25527989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU15983/99A Abandoned AU1598399A (en) | 1997-12-01 | 1998-11-30 | Injectable antifungal formulations |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU1598399A (en) |
| WO (1) | WO1999027932A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20020300A1 (en) | 2000-08-22 | 2002-05-10 | Pharmacia Corp | COMPOSITION OF SOLUTION OF AN ANTIBIOTIC DRUG BASED ON OXAZOLIDINONE WITH IMPROVEMENT OF DRUG LOAD |
| US7635773B2 (en) | 2008-04-28 | 2009-12-22 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions |
| DK2814849T3 (en) | 2012-02-15 | 2020-03-09 | Cydex Pharmaceuticals Inc | Process for Preparation of Cyclodextrin Derivatives |
| CN104704007A (en) | 2012-02-28 | 2015-06-10 | 锡德克斯药物公司 | Alkylated cyclodextrin compositions and methods of making and using same |
| SG11201503089WA (en) | 2012-10-22 | 2015-05-28 | Cydex Pharmaceuticals Inc | Alkylated cyclodextrin compositions and processes for preparing and using the same |
| FI3183295T3 (en) | 2014-08-22 | 2023-09-25 | Cydex Pharmaceuticals Inc | Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5661151A (en) * | 1993-12-21 | 1997-08-26 | Schering Corporation | Tetrahydrofuran antifungals |
-
1998
- 1998-11-30 WO PCT/US1998/024938 patent/WO1999027932A1/en not_active Ceased
- 1998-11-30 AU AU15983/99A patent/AU1598399A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999027932A1 (en) | 1999-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5636498A (en) | Pesticide composition | |
| AU2956297A (en) | Antifungal compositions with improved bioavailability | |
| AU5972598A (en) | Pesticide compositions | |
| AU5335798A (en) | Stomatic composition | |
| AU8747498A (en) | Food-preservative composition | |
| AU9663498A (en) | Sunscreen composition | |
| AU6827898A (en) | Detergent-package combination | |
| AU9066598A (en) | Substituted 4-benzoyl-pyrazoles | |
| AU3687297A (en) | Insecticidal composition | |
| AU1665999A (en) | Pesticidal composition | |
| AU5575398A (en) | Hairdye compositions | |
| AU1961799A (en) | Pesticidal composition | |
| AU8626598A (en) | Pesticidal compositions | |
| AU5844498A (en) | Antifungal composition | |
| AU8121998A (en) | Composition | |
| AU6525998A (en) | Improved metallo-endopeptidases | |
| AU1098499A (en) | Emulsifier-lipid composition | |
| AU6040398A (en) | Fungicidal compositions | |
| AU1873299A (en) | Deodorant composition | |
| AU1598399A (en) | Injectable antifungal formulations | |
| AU6090898A (en) | Substituted 4-benzoyl-pyrazoles | |
| AU1494099A (en) | Pesticidal compositions | |
| AUPP053197A0 (en) | Compositions | |
| AU6984998A (en) | Implement | |
| AU6128398A (en) | New composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |